Thromb Haemost 1993; 69(02): 185-191
DOI: 10.1055/s-0038-1651577
Original Article
Von Willebrand Disease
Schattauer GmbH Stuttgart

A Database of Polymorphisms in the von Willebrand Factor Gene and Pseudogene

For the Consortium on von Willebrand Factor Mutations and Polymorphisms [1], and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
J Evan Sadler
*   The Howard Hughes Medical Institute, The Jewish Hospital of St. Louis, Departments of Medicine, and of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO
,
David Ginsburg
**   Howard Hughes Medical Institute, Departments of Medicine and Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA
› Author Affiliations
Further Information

Publication History

Received 27 April 1992

Accepted after revision 07 October 1992

Publication Date:
03 July 2018 (online)

Summary

Nucleotide sequence polymorphisms in the von Willebrand factor (vWF) gene are useful for genetic studies in von Willebrand disease (vWD). This database describes 33 known vWF polymorphisms distributed throughout the vWF gene. DNA sequence information is available for 21 of these sites. The most informative system is a tetranucleotide repeat polymorphism in vWF intron 40. Sixteen of these polymorphisms are within vWF exons, and approximately half of them also alter the encoded amino acid sequence. Many occur close to mutations that cause vWD. The high prevalence of vWF polymorphisms must be considered in the analysis of candidate vWD mutations. In addition to the vWF gene on chromosome 12, there is a partial unprocessed vWF pseudogene on chromosome 22 that corresponds to vWF exons 23 to 34. Three polymorphisms have been assigned to the vWF pseudogene. Because the vWF gene and pseudogene have diverged only ∼3.1% in DNA sequence, correct assignment of polymorphisms to either locus can be difficult in the region of homology. This problem has been solved in some cases by comparison of the published sequences and predicted restriction maps for the gene and pseudogene.

Members of Consortium on von Willebrand Factor Mutations and Polymorphisms. Asterisks denote Steering Committee Members: Takeshi Abe, Tokyo University, Japan; Maria Anvret, Karolinska Hospital, Sweden; Javier Batlle, Hospital Teresa Herrera, Spain; Francesco Bernardi, Universita di Ferrara, Italy; David Bonthron, MRC Human Genetics Unit, Scotland; Derrick Bowen, University of Wales, Wales; Jeroen C. J. Eikenboom, University Hospital Leiden, The Netherlands; Bruce Ewenstein, Brigham and Women’s Hospital, USA; Gunnar Falk, Karolinksa Hospital, Sweden; David Ginsburg*, University of Michigan, USA; Harvey Grainick, National Institutes of Health, USA; Hiroshi Inaba*, Tokyo Medical College, Japan; Aida Inbal*, Beilinson Medical Center, Israel; David Lillicrap*, Queen’s University, Canada; David Mancuso, The Blood Center of Southeastern Wisconsin, USA; Claudine Mazurier*, Laboratoire de Recherche sur l’Hémostase, France; Dominique Meyer*, Hôpital de Bicêtre, France; Jan Michiels, Erasmus University, Rotterdam, The Netherlands; Robert Montgomery*, The Blood Center of Southeastern Wisconsin, USA; Ian Peake*, University of Sheffield, England; Anna M. Randi*, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Italy; J. Evan Sadler*, Washington University, USA; Hidehiko Saito*, Nagoya University, Japan; R. Schneppenheim, Universitäts-Kinderklinik Kiel, Germany; Jan J. Sixma*, Rijksuniversiteit te Utrecht, The Netherlands; Safia Wasi, The Canadian Red Cross, Canada: Gilbert White, University of North Carolina, USA; Paul Winter, Royal Victoria Hospital, Northern Ireland.


 
  • References

  • 1 Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns GAP, Latt SA, Orkin SH. Human von Willebrand factor (vWF): Isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-1406
  • 2 Verweij CL, de Vries CJM, Distel B, van Zonneveld A-J, van Kessel AG, van Mourik JA, Pannekoek H. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucleic Acids Res 1985; 13: 4699-4717
  • 3 Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von Willebrand factor. J Biol Chem 1990; 264: 19514-19527
  • 4 Patracchini P, Calzolari E, Aiello V, Palazzi P, Banin P, Marchetti G, Bernardi F. Sublocalization of von Willebrand factor pseudogene to 22q11.22-q11.23 by in situ hybridization in a 46,X,t(X;22) (pter;q11.21) translocation. Hum Genet 1989; 83: 264-266
  • 5 Mancuso DJ, Tuley EA, Westfield LA, Lester-Mancuso TL, Le Beau MM, Sorace JM, Sadler JE. Human von Willebrand factor gene and pseudogene: Structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991; 30: 253-269
  • 6 Bonthron DT, Orr EC, Mitsock LM, Ginsburg D, Handin RI, Orkin SH. Nucleotide sequence of pro-pro-von Willebrand factor cDNA. Nucleic Acids Res 1986; 14: 7125-7127
  • 7 Lynch DC, Zimmerman TS, Collins CJ, Brown M, Morin MJ, Ling EH, Livingston DM. Molecular cloning of cDNA for human von Willebrand factor. Authentication by a new method. Cell 1985; 41: 49-56
  • 8 Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394-6398
  • 9 Collins CJ, Underdahl JP, Levene RB, Ravera CP, Morin MJ, Dombalagian MJ, Ricca G, Livingston DM, Lynch DC. Molecular cloning of the human gene for von Willebrand factor and identification of the transcription initiation site. Proc Natl Acad Sci USA 1987; 84: 4393-4397
  • 10 Assouline Z, Kerbiriou-Nabias DM, Piétu G, Thomas N, Bahnak BR, Meyer D. The human gene for von Willebrand factor. Identification of repetitive Alu sequences 5’ to the transcription initiation site. Biochem Biophys Res Commun 1988; 153: 1159-1166
  • 11 Bonthron D, Orkin SH. The human von Willebrand factor gene. Structure of the 5’ region. Eur J Biochem 1988; 171: 51-57
  • 12 Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh DA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-3184
  • 13 Lavergne JM, Bahnak BR, Assouline Z, Piétu G, Kerbiriou-Nabias D, Meulien P, Pavirani A, Meyer D. A TaqI polymorphism in the 5’ region of the von Willebrand factor (vWF) gene. Nucleic Acids Res 1988; 16: 2742
  • 14 Marchetti G, Sacchi E, Patracchini P, Randi AM, Sampietro M, Bernardi F. Two additional TaqI RFLPs in von Willebrand factor gene (vWF) and pseudogene. Nucleic Acids Res 1989; 17: 3329
  • 15 Bernardi F, Marchetti G, Casonato A, Gemmati D, Patracchini P, Legnani C, DeRosa V, Girolami A, Conconi F. Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene. Br J Haematol 1990; 74: 282-289
  • 16 Inbal A, Handin RI. Two TaqI polymorphisms in the 5’ region of the von Willebrand factor (vWF) gene. Nucleic Acids Res 1989; 17: 10143
  • 17 Inbal A, Handin RI. StuI polymorphisms in the vWF gene. Nucleic Acids Res 1990; 18: 4959
  • 18 Iannuzzi MC, Konkle BA, Ginsburg D, Collins FS. Rsal RFLP in the human von Willebrand factor gene. Nucleic Acids Res 1987; 15: 5909
  • 19 Lindstedt M, Anvret M. An EcoRI polymorphism of the human von Willebrand factor cDNA (vWF). Nucleic Acids Res 1989; 17: 2882
  • 20 Ewerhardt B, Ludwig M, Schwaab R, Schneppenheim R, Olek K. An EcoRI polymorphism in the human von Willebrand factor (vWF) gene. Nucleic Acids Res 1989; 17: 5416
  • 21 Verweij CL, Hofker M, Quadt R, Briët E, Pannekoek H. RFLP for a human von Willebrand factor (vWF) cDNA clone, pvWF1100. Nucleic Acids Res 1989; 13: 8289
  • 22 Bahnak BR, Lavergne JM, Verweij CL, Rothschild C, Pannekoek H, Larrieu M-J, Meyer D. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms. Thromb Haemostas 1988; 60: 178-181
  • 23 Verweij CL, Quadt R, Briët E, Dubbeldam K, van Ommen GB, Pannekoek H. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand’s disease type II A. J Clin Invest 1988; 81: 1116-1121
  • 24 O’Connell P, Lathrop GM, Law M, Leppert M, Nakamura Y, Hoff M, Kumlin E, Thomas W, Eisner T, Ballard L, Goodman P, Azen E, Sadler JE, Lai GY, Lalouel J-M, White R. A primary genetic linkage map for human chromosome 12. Genomics 1987; 1: 93-102
  • 25 Bernardi F, Guerra S, Patracchini P, Volinia S, Buzzoni D, Ballerini G, Casonato A, Marchetti G. Von Willebrand disease investigated by two novel RFLPs. Br J Haematol 1988; 68: 243-248
  • 26 Quadt T, Verweij CL, de Vries CJM, Briët E, Pannekoek H. A polymorphic XbaI site within the human von Willebrand factor (vWF) gene identified by a vWF cDNA clone. Nucleic Acids Res 1986; 14: 7139
  • 27 Lavergne J-M, Bahnak BR, Verweij CL, Pannekoek H, Meyer D. A second XbaI polymorphic site within the human von Willebrand factor (vWF) gene. Nucleic Acids Res 1987; 15: 9099
  • 28 Caekebeke-Peerlinck KMJ, Bakker E, Briët E. An infrequent DNA polymorphism associated with severe von Willebrand’s disease. Br J Haematol 1990; 75: 78-81
  • 29 Konkle BA, Kim S, Iannuzzi MC, Alani R, Collins FS, Ginsburg D. SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Res 1987; 15: 6766
  • 30 Nishino K, Lynch DC. A polymorphism of the human von Willebrand factor (vWF) gene with BamHI. Nucleic Acids Res 1986; 14: 4697
  • 31 Bernardi F, Marchetti G, Bertagnolo V, Faggioli L, del Senno L. Two TaqI RFLPs in the human von Willebrand factor gene. Nucleic Acids Res 1987; 15: 1347
  • 32 Strain L, Bonthron DT, Brock DJH. SmaI and HhaI polymorphisms in the 5’ region of the human von Willebrand factor gene. Nucleic Acids Res 1991; 19: 4107
  • 33 Verweij CL, Diergaarde PJ, Hart M, Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J 1986; 5: 1839-1847
  • 34 Shelton-Inloes BB, Broze Jr GJ, Miletich JP, Sadler JE. Evolution of human von Willebrand factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand antigen II. Biochem Biophys Res Commun 1987; 144: 657-665
  • 35 Bowen DJ, Webb CE, Peake IR, Bloom AL. AatII polymorphism in von Willebrand factor gene at codon 471. Nucleic Acids Res 1991; 19: 3159
  • 36 Kunkel GR, Graham JB, Fowlkes DM, Lord ST. AccI polymorphism in von Willebrand factor (F8vWF) at codon 516. Nucleic Acids Res 1991; 19: 1729
  • 37 Kunkel GR, Graham JB, Fowlkes DM, Lord ST. Rsal polymorphism in von Willebrand factor (vWF) at codon 789. Nucleic Acids Res 1990; 18: 4961
  • 38 Shelton-Inloes BB, Titani K, Sadler JE. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 1986; 25: 3164-3171
  • 39 Nichols WC, Lyons SE, Harrison JS, Cody RL, Ginsburg D. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: Detection by exonic PCR-restriction fragment length polymorphism analysis. Proc Natl Acad Sci USA 1991; 88: 3857-3861
  • 40 Mercier B, Gaucher C, Mazurier C. An MspI polymorphism in the von Willebrand factor gene. Nucleic Acids Res 1990; 18: 7467
  • 41 Cacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant: A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 1991; 266: 13499-13502
  • 42 Bonthron DT, Handin RI, Kaufman RJ, Wasley LC, Orr EC, Mitsock. Ewenstein B, Loscalzo J, Ginsburg D, Orkin SH. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature 1986; 324: 270-273
  • 43 Donnér M, Holmberg L, Kristoffersson A-C, Nilsson IM. An HphI-polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand’s disease. Br J Haematol 1991; 78: 403-407
  • 44 Cooney KA, Nichols WC, Bruck ME, Bahou WF, Shapiro AD, Bowie EJW, Gralnick HR, Ginsburg D. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GPIb binding domain. J Clin Invest 1991; 87: 1227-1233
  • 45 Lavergne JM, Ribba AS, Bahnak BR, de Paillette L, Derlon A, Meyer D, Pietu G. The use of denaturing gradient gel electrophoresis to detect base changes in the von Willebrand factor gene from type IIA von Willebrand disease patients. Thromb Haemostas 1991; 65: 645
  • 46 Peake IR, Liddell MB, Moodie P, Standen G, Mancuso DJ, Tuley EA, Westfield LA, Sorace JM, Sadler JE, Verweij CL, Bloom AR. Severe type III von Willebrand’s disease caused by deletion of exon 42 of the von Willebrand factor gene: Family studies that identify carriers of the condition and a compound heterozygous individual. Blood 1990; 75: 654-661
  • 47 Ploos van Amstel HK, Reitsma PH. Tetranucleotide repeat polymorphism in the vWF gene. Nucleic Acids Res 1990; 18: 4957
  • 48 Peake IR, Bowen D, Bignell P, Liddell MB, Sadler JE, Standen G, Bloom AL. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene. Blood 1990; 76: 555-561
  • 49 Standen GR, Bignell P, Bowen DJ, Peake IR, Bloom AL. Family studies in von Willebrand’s disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence. Br J Haematol 1990; 76: 242-249
  • 50 Mercier B, Gaucher C, Mazurier C. Characterization of 98 alleles in 105 unrelated individuals in the F8vWF gene. Nucleic Acids Res 1991; 19: 4800
  • 51 Inbal A, Kornbrot N, Zivelin A, Shaklai M, Seligsohn U. The inheritance of type I and type III von Willebrand’s disease in Israel: Linkage analysis and carrier detection using two intragenic restriction fragment length polymorphisms. Blood Coag Fibrinol 1991; 3: 167-177
  • 52 Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 1984; 36: 131-138
  • 53 Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin and HLA-DQβ DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163-166
  • 54 Myers RM, Lumelsky N, Lerman LS, Maniatis T. Detection of single base substitutions in total genomic DNA. Nature 1985; 313: 495-498
  • 55 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879
  • 56 Driscoll CM, Chiu C, Hilgartner MW. A Kpnl DNA polymorphism in the human von Willebrand factor (vWF) gene. Nucleic Acids Res 1990; 18: 4968